Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Boulanger, Denis ^a   Sarr, Jean Biram ^b   Fillol, Florie ^a   Sokhna, Cheikh ^c   Cisse, Badara ^d   Schacht, Anne Marie ^e   Trape, Jean François ^c   Riveau, Gilles ^b   Simondon, François ^a   Greenwood, Brian ^f   Remoué, Franck ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b ONG Espoir Pour la Santé ^*  (Senegal)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^d UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^e INSERM U1019   (France)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ARTESUNATE PLUS PYRIMETHAMINE PLUS SULFADOXINE; HEMOGLOBIN; IMMUNOGLOBULIN G; PLACEBO; PROTOZOON ANTIBODY; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

AGE DISTRIBUTION; ANTIBODY RESPONSE; ARTICLE; ASEXUAL REPRODUCTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; NUTRITIONAL STATUS; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHIZONT; SENEGAL; SEX DIFFERENCE; BLOOD; CHEMOPROPHYLAXIS; DRUG COMBINATION; IMMUNOLOGY; INFANT; MALARIA; METHODOLOGY;

ANTIBODIES, PROTOZOAN; ANTIMALARIALS; ARTEMISININS; CHEMOPREVENTION; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALARIA; MALE; PLACEBOS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SENEGAL; SULFADOXINE;

EID: 78650145680     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-363     Document Type: Article

References (42)

1. Can malaria be eliminated? B Greenwood, Trans R Soc Trop Med Hyg 2009 103 Suppl 1 2 5 10.1016/j.trstmh.2008.10.027 19062058
2. Epidemiology and burden of malaria in pregnancy. M Desai FO ter Kuile F Nosten R McGready K Asamoa B Brabin RD Newman, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080
3. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. RW Snow M Craig U Deichmann K Marsh, Bull World Health Organ 1999 77 624 640 10516785
4. Intermittent preventive treatment of malaria in infants: how does it work and where will it work? RD Gosling I Carneiro D Chandramohan, Trop Med Int Health 2009 14 1003 1010 10.1111/j.1365-3156.2009.02303.x 19558374
5. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. B Cisse M Cairns E Faye ND O B Faye C Cames Y Cheng ND M AC Lo K Simondon JF Trape O Faye ND JL O Gaye B Greenwood P Milligan, PLoS One 2009 4 7164 10.1371/journal.pone.0007164 19784374
6. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. B Cisse C Sokhna D Boulanger J Milet H Ba el K Richardson R Hallett C Sutherland K Simondon F Simondon N Alexander O Gaye G Targett J Lines B Greenwood JF Trape, Lancet 2006 367 659 667 10.1016/S0140-6736(06)68264-0 16503464
7. Impact of intermittent preventive treatment with sulphadoxine- pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. A Dicko I Sagara MS Sissoko O Guindo AI Diallo M Kone OB Toure M Sacko OK Doumbo, Malar J 2008 7 123 10.1186/1475-2875-7-123 18611271
8. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. C Sokhna B Cisse H Ba el P Milligan R Hallett C Sutherland O Gaye D Boulanger K Simondon F Simondon G Targett J Lines B Greenwood JF Trape, PLoS One 2008 3 1471 10.1371/journal.pone.0001471 18213379
9. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. M Kweku D Liu M Adjuik F Binka M Seidu B Greenwood D Chandramohan, PLoS One 2008 3 4000 10.1371/journal.pone.0004000 19098989
10. Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali. B Barger H Maiga OB Traore M Tekete I Tembine A Dara ZI Traore S Gantt OK Doumbo AA Djimde, Trop Med Int Health 2009 14 784 791 10.1111/j.1365-3156.2009.02294.x 19497079
11. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. SE Clarke MC Jukes JK Njagi L Khasakhala B Cundill J Otido C Crudder BB Estambale S Brooker, Lancet 2008 372 127 138 10.1016/S0140-6736(08)61034-X 18620950
12. How might infant and paediatric immune responses influence malaria vaccine efficacy? AM Moormann, Parasite Immunol 2009 31 547 559 10.1111/j.1365-3024.2009.01137.x 19691558
13. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model. M Ramacher V Umansky T Efferth, Anticancer Drugs 2009 20 910 917 10.1097/CAD.0b013e328330caba 19745721
14. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. D Chandramohan S Owusu-Agyei I Carneiro T Awine K Amponsa-Achiano N Mensah S Jaffar R Baiden A Hodgson F Binka B Greenwood, BMJ 2005 331 727 733 10.1136/bmj.331.7519.727 16195288
15. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana. FP Mockenhaupt K Reither P Zanger F Roepcke I Danquah E Saad P Ziniel SY Dzisi M Frempong P Agana-Nsiire F Amoo-Sakyi R Otchwemah JP Cramer SD Anemana E Dietz U Bienzle, Antimicrob Agents Chemother 2007 51 3273 3281 10.1128/AAC.00513-07 17638703
16. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. JJ Aponte D Schellenberg A Egan A Breckenridge I Carneiro J Critchley I Danquah A Dodoo R Kobbe B Lell J May Z Premji S Sanz E Sevene R Soulaymani-Becheikh P Winstanley S Adjei S Anemana D Chandramohan S Issifou F Mockenhaupt S Owusu-Agyei B Greenwood MP Grobusch PG Kremsner E Macete H Mshinda RD Newman L Slutsker M Tanner P Alonso C Menendez, Lancet 2009 374 1533 1542 10.1016/S0140-6736(09)61258-7 19765816
17. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobano S Mabunda M DgeDge P Alonso C Menendez, J Infect Dis 2006 194 276 285 10.1086/505431 16826474
18. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. D Schellenberg C Menendez E Kahigwa J Aponte J Vidal M Tanner H Mshinda P Alonso, Lancet 2001 357 1471 1477 10.1016/S0140-6736(00)04643-2 11377597
19. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines. JB Rosen JG Breman CR Manclark BD Meade WE Collins HO Lobel P Saliou JM Roberts P Campaore MA Miller, Malar J 2005 4 53 10.1186/1475-2875-4-53 16271153
20. Impact of intermittent preventive treatment with sulfadoxine- pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique. D Quelhas L Puyol L Quinto E Serra-Casas T Nhampossa E Macete P Aide A Mayor I Mandomando S Sanz JJ Aponte VS Chauhan CE Chitnis PL Alonso C Menendez C Dobano, Clin Vaccine Immunol 2008 15 1282 1291 10.1128/CVI.00044-08 18495848
21. Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants. N Schreiber R Kobbe S Adjei O Adjei MQ Klinkert J May, Trop Med Int Health 2007 12 1157 1163 10.1111/j.1365-3156.2007.01902.x 17956497
22. Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. M Cairns R Gosling S Gesase J Mosha B Greenwood D Chandramohan, Trans R Soc Trop Med Hyg 2009 103 1199 1201 10.1016/j.trstmh.2009.06.007 19740503
23. Decline of infant and child mortality rates in rural Senegal over a 37-year period (1963-1999). V Delaunay JF Etard MP Preziosi A Marra F Simondon, Int J Epidemiol 2001 30 1286 1293 discussion 1294-1285 10.1093/ije/30.6.1286 11821330
24. Malaria transmission in the rural zone of Niakhar, Senegal. V Robert H Dieng L Lochouran SF Traore JF Trape F Simondon D Fontenille, Trop Med Int Health 1998 3 667 677 10.1046/j.1365-3156.1998.00288.x 9735937
25. Influence of wasting and stunting at the onset of the rainy season on subsequent malaria morbidity among rural preschool children in Senegal. F Fillol A Cournil D Boulanger B Cisse C Sokhna G Targett JF Trape F Simondon B Greenwood KB Simondon, Am J Trop Med Hyg 2009 80 202 208 19190214
26. Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response. F Fillol JB Sarr D Boulanger B Cisse C Sokhna G Riveau KB Simondon F Remoue, Malar J 2009 8 116 10.1186/1475-2875-8-116 19490641
27. Intermittent preventive therapy for malaria: progress and future directions. MP Grobusch A Egan RD Gosling RD Newman, Curr Opin Infect Dis 2007 20 613 620 10.1097/QCO.0b013e3282f1ae3b 17975412
28. Review: Intermittent preventive treatment - a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. B Greenwood, Trop Med Int Health 2006 11 983 991 10.1111/j.1365-3156.2006.01657.x 16827699
29. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. C Menendez E Kahigwa R Hirt P Vounatsou JJ Aponte F Font CJ Acosta DM Schellenberg CM Galindo J Kimario H Urassa B Brabin TA Smith AY Kitua M Tanner PL Alonso, Lancet 1997 350 844 850 10.1016/S0140-6736(97)04229-3 9310602
30. Effect of chloroquine on human lymphocyte proliferation. IC Bygbjerg H Flachs, Trans R Soc Trop Med Hyg 1986 80 231 235 10.1016/0035-9203(86)90021-0 3787684 (Pubitemid 17220696)
31. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. M Pappaioanou DB Fishbein DW Dreesen IK Schwartz GH Campbell JW Sumner LC Patchen WJ Brown, N Engl J Med 1986 314 280 284 10.1056/NEJM198601303140504 3510393
32. IPTi and Serological Responses to EPI Vaccines. D Goldblatt, SAGE Meeting Committee WA. Geneva 2009 http://www.who.int/immunization/sage/D-Goldbatt-IPTi- EPI-Serology-FINAL.pdf
33. Intermittent presumptive treatment for malaria. NJ White, PLoS Med 2005 2 3 10.1371/journal.pmed.0020003 15696210
34. Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. M Cairns I Carneiro P Milligan S Owusu-Agyei T Awine R Gosling B Greenwood D Chandramohan, PLoS ONE 2008 3 2227 10.1371/journal.pone.0002227 18493597
35. Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon. J May S Adjei W Busch JJ Gabor S Issifou R Kobbe B Kreuels B Lell NG Schwarz O Adjei PG Kremsner MP Grobusch, Malar J 2008 7 198 18828899
36. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. R Kobbe C Kreuzberg S Adjei B Thompson I Langefeld PA Thompson HH Abruquah B Kreuels M Ayim W Busch F Marks K Amoah E Opoku CG Meyer O Adjei J May, Clin Infect Dis 2007 45 16 25 10.1086/518575 17554695
37. Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. JB Sarr F Remoue B Samb I Dia S Guindo C Sow S Maiga S Tine C Thiam AM Schacht F Simondon L Konate G Riveau, Malar J 2007 6 117 10.1186/1475-2875-6-117 17764568
38. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. OJ Akpogheneta NO Duah KK Tetteh S Dunyo DE Lanar M Pinder DJ Conway, Infect Immun 2008 76 1748 1755 10.1128/IAI.01333-07 18212081
39. Immune effector mechanisms in malaria. K Marsh S Kinyanjui, Parasite Immunol 2006 28 51 60 10.1111/j.1365-3024.2006.00808.x 16438676
40. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. D Courtin M Oesterholt H Huismans K Kusi J Milet C Badaut O Gaye W Roeffen EJ Remarque R Sauerwein A Garcia AJ Luty, PLoS One 2009 4 7590 10.1371/journal. pone.0007590 19859562
41. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. BM Greenwood PH David LN Otoo-Forbes SJ Allen PL Alonso JR Armstrong Schellenberg P Byass M Hurwitz A Menon RW Snow, Trans R Soc Trop Med Hyg 1995 89 629 633 10.1016/0035-9203(95)90419-0 8594677
42. Response to Buffet, et al. Intermittent preventive anti-malarial treatment to children (IPTc): firebreak or fire trap? B Greenwood K Bojang D Chandramohan B Cisse M Kweku P Milligan, Trends Parasitol 2008 24 485 486 10.1016/j.pt.2008.08.003